Exodus Point Capital Management, LP Vertex Pharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

$14.7 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $21.3 Million - $23.3 Million	52,300 New	52,300 $21.9 Million
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $9.65 Million - $11 Million	34,073 Added 111.83%	64,541 $20.3 Million
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $8.71 Million - $9.79 Million	30,468 New	30,468 $8.8 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $1.03 Million - $1.15 Million	-3,751 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$234.96 - $292.55 $881,334 - $1.1 Million	3,751 New	3,751 $1.06 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $9.95 Million - $11.7 Million	-44,933 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$177.01 - $223.45 $1.03 Million - $1.3 Million	5,821 Added 14.88%	44,933 $9.87 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $2.44 Million - $2.73 Million	13,450 Added 52.41%	39,112 $7.1 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $3.01 Million - $3.55 Million	16,065 Added 167.4%	25,662 $5.17 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $1.93 Million - $2.25 Million	-9,316 Reduced 49.26%	9,597 $2.06 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $2.5 Million - $3.34 Million	12,091 Added 177.24%	18,913 $4.47 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $1.99 Million - $2.36 Million	-7,786 Reduced 53.3%	6,822 $1.86 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $2.79 Million - $3.66 Million	12,370 Added 552.73%	14,608 $4.24 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $447,085 - $554,598	2,238 New	2,238 $533,000
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $1.46 Million - $1.97 Million	-8,776 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $325,145 - $365,948	1,956 Added 28.68%	8,776 $1.49 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $1.12 Million - $1.3 Million	6,820 New	6,820 $1.25 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account